QuidelOrtho Corporation
QuidelOrtho Corporation QDEL Peers
See (QDEL) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| QDEL | $28.82 | -0.17% | 1.9B | -5.51 | -$5.23 | N/A |
| ISRG | $543.41 | +1.82% | 194.8B | 79.56 | $6.83 | N/A |
| BDX | $172.25 | +0.81% | 49.4B | 33.37 | $5.16 | +2.37% |
| BDXA | $59.24 | -2.24% | 48.7B | 21.44 | $2.76 | +2.37% |
| ALC | $88.28 | +0.54% | 43.7B | 39.24 | $2.25 | +0.38% |
| RMD | $258.00 | +1.11% | 37.8B | 28.96 | $8.91 | +0.82% |
| WST | $218.80 | -0.03% | 15.7B | 34.35 | $6.37 | +0.38% |
| BAX | $30.28 | -0.36% | 15.5B | -58.22 | -$0.52 | +2.64% |
| HOLX | $65.16 | +0.23% | 14.5B | 27.38 | $2.38 | N/A |
| COO | $71.16 | +0.03% | 14.2B | 34.38 | $2.07 | N/A |
Stock Comparison
QDEL vs ISRG Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ISRG has a market cap of 194.8B. Regarding current trading prices, QDEL is priced at $28.82, while ISRG trades at $543.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ISRG's P/E ratio is 79.56. In terms of profitability, QDEL's ROE is -0.11%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, QDEL is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs BDX Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, BDX has a market cap of 49.4B. Regarding current trading prices, QDEL is priced at $28.82, while BDX trades at $172.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas BDX's P/E ratio is 33.37. In terms of profitability, QDEL's ROE is -0.11%, compared to BDX's ROE of +0.06%. Regarding short-term risk, QDEL is more volatile compared to BDX. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs BDXA Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, BDXA has a market cap of 48.7B. Regarding current trading prices, QDEL is priced at $28.82, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas BDXA's P/E ratio is 21.44. In terms of profitability, QDEL's ROE is -0.11%, compared to BDXA's ROE of +0.06%. Regarding short-term risk, QDEL is less volatile compared to BDXA. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs ALC Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ALC has a market cap of 43.7B. Regarding current trading prices, QDEL is priced at $28.82, while ALC trades at $88.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ALC's P/E ratio is 39.24. In terms of profitability, QDEL's ROE is -0.11%, compared to ALC's ROE of +0.07%. Regarding short-term risk, QDEL is more volatile compared to ALC. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs RMD Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, RMD has a market cap of 37.8B. Regarding current trading prices, QDEL is priced at $28.82, while RMD trades at $258.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas RMD's P/E ratio is 28.96. In terms of profitability, QDEL's ROE is -0.11%, compared to RMD's ROE of +0.25%. Regarding short-term risk, QDEL is more volatile compared to RMD. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs WST Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, WST has a market cap of 15.7B. Regarding current trading prices, QDEL is priced at $28.82, while WST trades at $218.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas WST's P/E ratio is 34.35. In terms of profitability, QDEL's ROE is -0.11%, compared to WST's ROE of +0.17%. Regarding short-term risk, QDEL is more volatile compared to WST. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs BAX Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, BAX has a market cap of 15.5B. Regarding current trading prices, QDEL is priced at $28.82, while BAX trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas BAX's P/E ratio is -58.22. In terms of profitability, QDEL's ROE is -0.11%, compared to BAX's ROE of -0.08%. Regarding short-term risk, QDEL is more volatile compared to BAX. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs HOLX Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, HOLX has a market cap of 14.5B. Regarding current trading prices, QDEL is priced at $28.82, while HOLX trades at $65.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas HOLX's P/E ratio is 27.38. In terms of profitability, QDEL's ROE is -0.11%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, QDEL is more volatile compared to HOLX. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs COO Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, COO has a market cap of 14.2B. Regarding current trading prices, QDEL is priced at $28.82, while COO trades at $71.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas COO's P/E ratio is 34.38. In terms of profitability, QDEL's ROE is -0.11%, compared to COO's ROE of +0.05%. Regarding short-term risk, QDEL is more volatile compared to COO. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs BDXB Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, QDEL is priced at $28.82, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas BDXB's P/E ratio is 7.60. In terms of profitability, QDEL's ROE is -0.11%, compared to BDXB's ROE of +0.06%. Regarding short-term risk, QDEL is more volatile compared to BDXB. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs ATR Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ATR has a market cap of 10.3B. Regarding current trading prices, QDEL is priced at $28.82, while ATR trades at $156.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ATR's P/E ratio is 28.60. In terms of profitability, QDEL's ROE is -0.11%, compared to ATR's ROE of +0.15%. Regarding short-term risk, QDEL is more volatile compared to ATR. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs MASI Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, MASI has a market cap of 9.1B. Regarding current trading prices, QDEL is priced at $28.82, while MASI trades at $168.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas MASI's P/E ratio is -30.75. In terms of profitability, QDEL's ROE is -0.11%, compared to MASI's ROE of -0.41%. Regarding short-term risk, QDEL is more volatile compared to MASI. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs RGEN Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, RGEN has a market cap of 7B. Regarding current trading prices, QDEL is priced at $28.82, while RGEN trades at $124.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas RGEN's P/E ratio is -296.14. In terms of profitability, QDEL's ROE is -0.11%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, QDEL is more volatile compared to RGEN. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs STVN Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, STVN has a market cap of 6.7B. Regarding current trading prices, QDEL is priced at $28.82, while STVN trades at $24.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas STVN's P/E ratio is 46.15. In terms of profitability, QDEL's ROE is -0.11%, compared to STVN's ROE of +0.09%. Regarding short-term risk, QDEL is more volatile compared to STVN. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs MMSI Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, MMSI has a market cap of 5.5B. Regarding current trading prices, QDEL is priced at $28.82, while MMSI trades at $93.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas MMSI's P/E ratio is 45.82. In terms of profitability, QDEL's ROE is -0.11%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, QDEL is more volatile compared to MMSI. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs TFX Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, TFX has a market cap of 5.2B. Regarding current trading prices, QDEL is priced at $28.82, while TFX trades at $118.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas TFX's P/E ratio is 36.63. In terms of profitability, QDEL's ROE is -0.11%, compared to TFX's ROE of +0.03%. Regarding short-term risk, QDEL is more volatile compared to TFX. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs BLCO Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, BLCO has a market cap of 4.6B. Regarding current trading prices, QDEL is priced at $28.82, while BLCO trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas BLCO's P/E ratio is -12.75. In terms of profitability, QDEL's ROE is -0.11%, compared to BLCO's ROE of -0.08%. Regarding short-term risk, QDEL is less volatile compared to BLCO. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs HAE Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, QDEL is priced at $28.82, while HAE trades at $74.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas HAE's P/E ratio is 22.54. In terms of profitability, QDEL's ROE is -0.11%, compared to HAE's ROE of +0.18%. Regarding short-term risk, QDEL is more volatile compared to HAE. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs ICUI Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ICUI has a market cap of 3.3B. Regarding current trading prices, QDEL is priced at $28.82, while ICUI trades at $132.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ICUI's P/E ratio is -34.50. In terms of profitability, QDEL's ROE is -0.11%, compared to ICUI's ROE of -0.05%. Regarding short-term risk, QDEL is more volatile compared to ICUI. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs XRAY Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, XRAY has a market cap of 3.2B. Regarding current trading prices, QDEL is priced at $28.82, while XRAY trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas XRAY's P/E ratio is -3.55. In terms of profitability, QDEL's ROE is -0.11%, compared to XRAY's ROE of -0.38%. Regarding short-term risk, QDEL is more volatile compared to XRAY. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs WRBY Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, WRBY has a market cap of 2.7B. Regarding current trading prices, QDEL is priced at $28.82, while WRBY trades at $21.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas WRBY's P/E ratio is -182.62. In terms of profitability, QDEL's ROE is -0.11%, compared to WRBY's ROE of -0.04%. Regarding short-term risk, QDEL is more volatile compared to WRBY. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs NVCR Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, QDEL is priced at $28.82, while NVCR trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas NVCR's P/E ratio is -11.82. In terms of profitability, QDEL's ROE is -0.11%, compared to NVCR's ROE of -0.45%. Regarding short-term risk, QDEL is less volatile compared to NVCR. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs LMAT Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, QDEL is priced at $28.82, while LMAT trades at $83.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas LMAT's P/E ratio is 42.16. In terms of profitability, QDEL's ROE is -0.11%, compared to LMAT's ROE of +0.14%. Regarding short-term risk, QDEL is more volatile compared to LMAT. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs ATRC Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ATRC has a market cap of 1.6B. Regarding current trading prices, QDEL is priced at $28.82, while ATRC trades at $32.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ATRC's P/E ratio is -40.46. In terms of profitability, QDEL's ROE is -0.11%, compared to ATRC's ROE of -0.08%. Regarding short-term risk, QDEL is more volatile compared to ATRC. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs AZTA Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, AZTA has a market cap of 1.4B. Regarding current trading prices, QDEL is priced at $28.82, while AZTA trades at $30.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas AZTA's P/E ratio is -9.41. In terms of profitability, QDEL's ROE is -0.11%, compared to AZTA's ROE of -0.04%. Regarding short-term risk, QDEL is more volatile compared to AZTA. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs NNNN Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, NNNN has a market cap of 1.4B. Regarding current trading prices, QDEL is priced at $28.82, while NNNN trades at $31.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas NNNN's P/E ratio is 633.20. In terms of profitability, QDEL's ROE is -0.11%, compared to NNNN's ROE of +0.14%. Regarding short-term risk, QDEL is less volatile compared to NNNN. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs BLFS Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, BLFS has a market cap of 1B. Regarding current trading prices, QDEL is priced at $28.82, while BLFS trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas BLFS's P/E ratio is -113.37. In terms of profitability, QDEL's ROE is -0.11%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, QDEL is more volatile compared to BLFS. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs PLSE Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, PLSE has a market cap of 1B. Regarding current trading prices, QDEL is priced at $28.82, while PLSE trades at $15.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas PLSE's P/E ratio is -15.24. In terms of profitability, QDEL's ROE is -0.11%, compared to PLSE's ROE of -0.71%. Regarding short-term risk, QDEL is more volatile compared to PLSE. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs KMTS Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, KMTS has a market cap of 851.4M. Regarding current trading prices, QDEL is priced at $28.82, while KMTS trades at $16.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas KMTS's P/E ratio is -8.64. In terms of profitability, QDEL's ROE is -0.11%, compared to KMTS's ROE of +0.27%. Regarding short-term risk, QDEL is less volatile compared to KMTS. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs STAA Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, STAA has a market cap of 830.6M. Regarding current trading prices, QDEL is priced at $28.82, while STAA trades at $16.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas STAA's P/E ratio is -11.65. In terms of profitability, QDEL's ROE is -0.11%, compared to STAA's ROE of -0.18%. Regarding short-term risk, QDEL is more volatile compared to STAA. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs ATRI Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, QDEL is priced at $28.82, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ATRI's P/E ratio is 64.50. In terms of profitability, QDEL's ROE is -0.11%, compared to ATRI's ROE of +0.04%. Regarding short-term risk, QDEL is more volatile compared to ATRI. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs ANGO Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ANGO has a market cap of 402.8M. Regarding current trading prices, QDEL is priced at $28.82, while ANGO trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ANGO's P/E ratio is -9.82. In terms of profitability, QDEL's ROE is -0.11%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, QDEL is more volatile compared to ANGO. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs NYXH Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, NYXH has a market cap of 280M. Regarding current trading prices, QDEL is priced at $28.82, while NYXH trades at $7.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas NYXH's P/E ratio is -3.21. In terms of profitability, QDEL's ROE is -0.11%, compared to NYXH's ROE of -0.56%. Regarding short-term risk, QDEL is less volatile compared to NYXH. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs SMTI Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, SMTI has a market cap of 252.3M. Regarding current trading prices, QDEL is priced at $28.82, while SMTI trades at $28.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas SMTI's P/E ratio is -21.19. In terms of profitability, QDEL's ROE is -0.11%, compared to SMTI's ROE of -0.29%. Regarding short-term risk, QDEL is more volatile compared to SMTI. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs OSUR Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, OSUR has a market cap of 224.4M. Regarding current trading prices, QDEL is priced at $28.82, while OSUR trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas OSUR's P/E ratio is -7.14. In terms of profitability, QDEL's ROE is -0.11%, compared to OSUR's ROE of -0.08%. Regarding short-term risk, QDEL is more volatile compared to OSUR. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs UTMD Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, UTMD has a market cap of 184.9M. Regarding current trading prices, QDEL is priced at $28.82, while UTMD trades at $56.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas UTMD's P/E ratio is 15.02. In terms of profitability, QDEL's ROE is -0.11%, compared to UTMD's ROE of +0.11%. Regarding short-term risk, QDEL is more volatile compared to UTMD. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs STXS Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, STXS has a market cap of 182.3M. Regarding current trading prices, QDEL is priced at $28.82, while STXS trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas STXS's P/E ratio is -6.84. In terms of profitability, QDEL's ROE is -0.11%, compared to STXS's ROE of -2.17%. Regarding short-term risk, QDEL is less volatile compared to STXS. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs KRMD Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, KRMD has a market cap of 165.2M. Regarding current trading prices, QDEL is priced at $28.82, while KRMD trades at $3.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas KRMD's P/E ratio is -29.83. In terms of profitability, QDEL's ROE is -0.11%, compared to KRMD's ROE of -0.30%. Regarding short-term risk, QDEL is less volatile compared to KRMD. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs PDEX Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, PDEX has a market cap of 142.3M. Regarding current trading prices, QDEL is priced at $28.82, while PDEX trades at $43.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas PDEX's P/E ratio is 15.81. In terms of profitability, QDEL's ROE is -0.11%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, QDEL is less volatile compared to PDEX. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs INFU Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, INFU has a market cap of 130.6M. Regarding current trading prices, QDEL is priced at $28.82, while INFU trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas INFU's P/E ratio is 41.50. In terms of profitability, QDEL's ROE is -0.11%, compared to INFU's ROE of +0.08%. Regarding short-term risk, QDEL is less volatile compared to INFU. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs ZTEK Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ZTEK has a market cap of 113.7M. Regarding current trading prices, QDEL is priced at $28.82, while ZTEK trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ZTEK's P/E ratio is -15.57. In terms of profitability, QDEL's ROE is -0.11%, compared to ZTEK's ROE of -0.58%. Regarding short-term risk, QDEL is less volatile compared to ZTEK. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs ZJYL Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ZJYL has a market cap of 102.1M. Regarding current trading prices, QDEL is priced at $28.82, while ZJYL trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ZJYL's P/E ratio is 32.60. In terms of profitability, QDEL's ROE is -0.11%, compared to ZJYL's ROE of +0.13%. Regarding short-term risk, QDEL is less volatile compared to ZJYL. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs MBOT Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, MBOT has a market cap of 91.7M. Regarding current trading prices, QDEL is priced at $28.82, while MBOT trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas MBOT's P/E ratio is -3.94. In terms of profitability, QDEL's ROE is -0.11%, compared to MBOT's ROE of -0.85%. Regarding short-term risk, QDEL and MBOT have similar daily volatility (4.32).
QDEL vs AKYA Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, AKYA has a market cap of 64.9M. Regarding current trading prices, QDEL is priced at $28.82, while AKYA trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas AKYA's P/E ratio is -1.35. In terms of profitability, QDEL's ROE is -0.11%, compared to AKYA's ROE of -5.06%. Regarding short-term risk, QDEL is less volatile compared to AKYA. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs OMIC Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, QDEL is priced at $28.82, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas OMIC's P/E ratio is -0.58. In terms of profitability, QDEL's ROE is -0.11%, compared to OMIC's ROE of -0.58%. Regarding short-term risk, QDEL is more volatile compared to OMIC. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs IGAP Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, QDEL is priced at $28.82, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas IGAP's P/E ratio is -10.52. In terms of profitability, QDEL's ROE is -0.11%, compared to IGAP's ROE of +3.93%. Regarding short-term risk, QDEL is more volatile compared to IGAP. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs MLSS Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, MLSS has a market cap of 49.9M. Regarding current trading prices, QDEL is priced at $28.82, while MLSS trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas MLSS's P/E ratio is -10.60. In terms of profitability, QDEL's ROE is -0.11%, compared to MLSS's ROE of -0.83%. Regarding short-term risk, QDEL is less volatile compared to MLSS. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs DXR Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, DXR has a market cap of 48.6M. Regarding current trading prices, QDEL is priced at $28.82, while DXR trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas DXR's P/E ratio is -108.78. In terms of profitability, QDEL's ROE is -0.11%, compared to DXR's ROE of +0.02%. Regarding short-term risk, QDEL is more volatile compared to DXR. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs NEPH Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, NEPH has a market cap of 43.2M. Regarding current trading prices, QDEL is priced at $28.82, while NEPH trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas NEPH's P/E ratio is 51.00. In terms of profitability, QDEL's ROE is -0.11%, compared to NEPH's ROE of +0.09%. Regarding short-term risk, QDEL is less volatile compared to NEPH. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs POCI Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, POCI has a market cap of 37.6M. Regarding current trading prices, QDEL is priced at $28.82, while POCI trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas POCI's P/E ratio is -5.38. In terms of profitability, QDEL's ROE is -0.11%, compared to POCI's ROE of -0.54%. Regarding short-term risk, QDEL is less volatile compared to POCI. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs SDC Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, QDEL is priced at $28.82, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas SDC's P/E ratio is -0.03. In terms of profitability, QDEL's ROE is -0.11%, compared to SDC's ROE of -1.96%. Regarding short-term risk, QDEL is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs FEMY Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, FEMY has a market cap of 28.2M. Regarding current trading prices, QDEL is priced at $28.82, while FEMY trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas FEMY's P/E ratio is -1.06. In terms of profitability, QDEL's ROE is -0.11%, compared to FEMY's ROE of -3.92%. Regarding short-term risk, QDEL is more volatile compared to FEMY. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs IVC Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, QDEL is priced at $28.82, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas IVC's P/E ratio is -0.79. In terms of profitability, QDEL's ROE is -0.11%, compared to IVC's ROE of -0.46%. Regarding short-term risk, QDEL is less volatile compared to IVC. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs NXGL Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, NXGL has a market cap of 19.7M. Regarding current trading prices, QDEL is priced at $28.82, while NXGL trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas NXGL's P/E ratio is -5.73. In terms of profitability, QDEL's ROE is -0.11%, compared to NXGL's ROE of -0.63%. Regarding short-term risk, QDEL is less volatile compared to NXGL. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs HBIO Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, HBIO has a market cap of 19.6M. Regarding current trading prices, QDEL is priced at $28.82, while HBIO trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas HBIO's P/E ratio is -0.34. In terms of profitability, QDEL's ROE is -0.11%, compared to HBIO's ROE of -1.10%. Regarding short-term risk, QDEL is less volatile compared to HBIO. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs RVP Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, RVP has a market cap of 19.1M. Regarding current trading prices, QDEL is priced at $28.82, while RVP trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas RVP's P/E ratio is -0.84. In terms of profitability, QDEL's ROE is -0.11%, compared to RVP's ROE of -0.27%. Regarding short-term risk, QDEL is less volatile compared to RVP. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs WOK Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, WOK has a market cap of 17.4M. Regarding current trading prices, QDEL is priced at $28.82, while WOK trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas WOK's P/E ratio is -2.59. In terms of profitability, QDEL's ROE is -0.11%, compared to WOK's ROE of -0.30%. Regarding short-term risk, QDEL is more volatile compared to WOK. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs NXGLW Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, NXGLW has a market cap of 16.4M. Regarding current trading prices, QDEL is priced at $28.82, while NXGLW trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas NXGLW's P/E ratio is -0.18. In terms of profitability, QDEL's ROE is -0.11%, compared to NXGLW's ROE of -0.63%. Regarding short-term risk, QDEL is less volatile compared to NXGLW. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs LUCYW Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, LUCYW has a market cap of 13.8M. Regarding current trading prices, QDEL is priced at $28.82, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas LUCYW's P/E ratio is N/A. In terms of profitability, QDEL's ROE is -0.11%, compared to LUCYW's ROE of -0.95%. Regarding short-term risk, QDEL is less volatile compared to LUCYW. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs MHUA Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, MHUA has a market cap of 12.7M. Regarding current trading prices, QDEL is priced at $28.82, while MHUA trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas MHUA's P/E ratio is 1.00. In terms of profitability, QDEL's ROE is -0.11%, compared to MHUA's ROE of +0.09%. Regarding short-term risk, QDEL is less volatile compared to MHUA. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs EKSO Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, EKSO has a market cap of 7.9M. Regarding current trading prices, QDEL is priced at $28.82, while EKSO trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas EKSO's P/E ratio is -0.46. In terms of profitability, QDEL's ROE is -0.11%, compared to EKSO's ROE of -0.82%. Regarding short-term risk, QDEL is less volatile compared to EKSO. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs POAI Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, POAI has a market cap of 7.4M. Regarding current trading prices, QDEL is priced at $28.82, while POAI trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas POAI's P/E ratio is -0.58. In terms of profitability, QDEL's ROE is -0.11%, compared to POAI's ROE of -5.91%. Regarding short-term risk, QDEL is more volatile compared to POAI. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs LUCY Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, LUCY has a market cap of 6.6M. Regarding current trading prices, QDEL is priced at $28.82, while LUCY trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas LUCY's P/E ratio is 0.05. In terms of profitability, QDEL's ROE is -0.11%, compared to LUCY's ROE of -0.95%. Regarding short-term risk, QDEL is less volatile compared to LUCY. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs STSS Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, STSS has a market cap of 5.6M. Regarding current trading prices, QDEL is priced at $28.82, while STSS trades at $5.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas STSS's P/E ratio is N/A. In terms of profitability, QDEL's ROE is -0.11%, compared to STSS's ROE of -0.99%. Regarding short-term risk, QDEL is less volatile compared to STSS. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs NSTG Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, QDEL is priced at $28.82, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas NSTG's P/E ratio is -0.03. In terms of profitability, QDEL's ROE is -0.11%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, QDEL is less volatile compared to NSTG. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs GCTK Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, GCTK has a market cap of 3.4M. Regarding current trading prices, QDEL is priced at $28.82, while GCTK trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas GCTK's P/E ratio is N/A. In terms of profitability, QDEL's ROE is -0.11%, compared to GCTK's ROE of +3.93%. Regarding short-term risk, QDEL is less volatile compared to GCTK. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs GMVD Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, QDEL is priced at $28.82, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas GMVD's P/E ratio is -0.01. In terms of profitability, QDEL's ROE is -0.11%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, QDEL is less volatile compared to GMVD. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs GMVDW Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, QDEL is priced at $28.82, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas GMVDW's P/E ratio is N/A. In terms of profitability, QDEL's ROE is -0.11%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, QDEL is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs AVGR Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, QDEL is priced at $28.82, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas AVGR's P/E ratio is -0.05. In terms of profitability, QDEL's ROE is -0.11%, compared to AVGR's ROE of -54.25%. Regarding short-term risk, QDEL is less volatile compared to AVGR. This indicates potentially lower risk in terms of short-term price fluctuations for QDEL.
QDEL vs LMNX Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, LMNX has a market cap of 0. Regarding current trading prices, QDEL is priced at $28.82, while LMNX trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas LMNX's P/E ratio is N/A. In terms of profitability, QDEL's ROE is -0.11%, compared to LMNX's ROE of +0.03%. Regarding short-term risk, QDEL is more volatile compared to LMNX. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs IIN Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, IIN has a market cap of 0. Regarding current trading prices, QDEL is priced at $28.82, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas IIN's P/E ratio is 226.45. In terms of profitability, QDEL's ROE is -0.11%, compared to IIN's ROE of -0.00%. Regarding short-term risk, QDEL is more volatile compared to IIN. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs APR Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, APR has a market cap of 0. Regarding current trading prices, QDEL is priced at $28.82, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas APR's P/E ratio is 22.59. In terms of profitability, QDEL's ROE is -0.11%, compared to APR's ROE of +9.81%. Regarding short-term risk, QDEL is more volatile compared to APR. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs ATRS Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, QDEL is priced at $28.82, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas ATRS's P/E ratio is 14.95. In terms of profitability, QDEL's ROE is -0.11%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, QDEL is more volatile compared to ATRS. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.
QDEL vs HRC Comparison
QDEL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 1.9B. In comparison, HRC has a market cap of 0. Regarding current trading prices, QDEL is priced at $28.82, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of -5.51, whereas HRC's P/E ratio is 41.92. In terms of profitability, QDEL's ROE is -0.11%, compared to HRC's ROE of +0.14%. Regarding short-term risk, QDEL is more volatile compared to HRC. This indicates potentially higher risk in terms of short-term price fluctuations for QDEL.